Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM analyst Rohit Kulkarni reiterated a Buy rating on Alphabet Class A (GOOGL – Research Report) today and set a price target of $225.00.

Roth MKM analyst Rohit Kulkarni reiterated a Buy rating on Amazon (AMZN – Research Report) today and set a price target of $260.00. The ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Chardan Capital Markets has recently initiated Mind Medicine (MindMed) Inc (MNMD) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on October 14, 2024, Leerink ...

Terawulf Inc (WULF) stock saw a modest uptick, ending the day at $6.4 which represents a slight increase of $0.55 or 9.40% from the prior close of $5.85. The stock opened at $6.22 and touched a low of ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Cingulate (NasdaqCM:CING) with a Buy recommendation.

American Superconductor (NASDAQ:AMSC – Get Free Report) is expected to be announcing its earnings results before the market ...

Shares of D-Wave Quantum Inc. (NYSE:QBTS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () (NasdaqGM:VRNA) with a Buy recommendation. As of December 23, 2024, the average ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...